IVY RAY: Open Payments
NPI 1922623677 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 43 payments from 16 companies in 2025. Trend: 2023 $1,087 · 2024 $747 · 2025 $876
Food & beverage: $876
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 4 | $95 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| Mallinckrodt Hospital Products Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| Travere Therapeutics, Inc. | 4 | $71 |
| Vifor Pharma, Inc. | 3 | $57 |
| Fresenius USA Marketing, Inc. | 3 | $56 |
| Ascendis Pharma Endocrinology Inc | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
Products named: TARPEYO, JARDIANCE, JYNARQUE, Fabhalta, ACTHAR, Veltassa, VELPHORO, Yorvipath.
Industry payments across SC — which companies pay providers there.
